Career

Pelvital Appoints Ryan Willemsen as New COO to Support the Commercialization of Flyte, the Company’s Non-Surgical Treatment for Female Stress Urinary Incontinence

Pelvital, a privately held medical device company that has developed Flyte, a clinically proven, FDA-cleared, non-surgical treatment for female stress urinary incontinence (SUI), announced today that Ryan Willemsen has been appointed Chief Operations Officer. In this role, Willemsen will be responsible for leading the operations of Pelvital with a focus on market adoption of Flyte, building a global sales and distribution capability,…

Maven Expands Its Women’s and Familty Health Offering as Dr. Neel Shah Becomes the Company’s New Chief Medical Officer

Maven, the leading virtual clinic for women’s and family health, today announced that it has hired Dr. Neel Shah, MD, MPP, FACOG, as Chief Medical Officer. A globally recognized expert in designing solutions that improve health care, Dr. Shah brings deep experience as a physician, professor and social entrepreneur to Maven. “Joining Maven presents a unique opportunity for me to build the…

Jill Spear Joins Volpara as Executive Vice President Of Sales & Marketing to Grow the Company’s AI-Powered Breast Health Platform

Volpara Health has announced Jill Spear as the new Executive Vice President of Sales and Marketing who will drive continued growth for Volpara’s integrated software platform that assists in the delivery of personalized breast care. In this role, Spear will expand sales of the company’s breast cancer risk assessment, detection, imaging analytics and patient tracking software in North America. Earlier this year, Volpara acquired CRA Health,…

Womens Health Focused Psychedelics Startup Eastra Health Appoints Veteran Pharmacologist and Neuroscientist Emeline Maillet Ph.D. as Chief Scientific Officer

Women’s health focused psychedelics startup Eastra Health has announced Emeline Maillet Ph.D. as Chief Scientific Officer. Dr. Maillet is a leading pharmacologist and neuroscientist with over twenty years of experience in academia and pharmaceuticals identifying and testing novel drug treatments for various conditions. Eastra Health is a biotech company dedicated to developing psychedelic-derived medicines designed for women. The company focuses on under-addressed…

Dr. Stephen Palmer Joins the Celmatix Executive Team to Lead the Company’s Drug Discovery and Development Efforts in Ovarian Health as Chief Scientific Officer

Women’s Health Biotech Celmatix focused uniquely on ovarian biology has announced the appointment of Dr. Stephen Palmer as Chief Scientific Officer. Dr. Palmer had previously joined the company’s Scientific Advisory Board earlier this year, on the heels of rapid progress with Celmatix’s lead AMHR2 agonist program and the out-licensing of PCOS targets from its multi-omics ovarian health platform. Dr. Palmer is a…

Carrot Fertility Expands Leadership Team to Further Accelerate Growth

Global benefits provider Carrot Fertility has recently announced the expansion of its leadership team with three new hires: Julie Chavez joins as Vice President of Strategy and Alliances from global consulting firm Willis Towers Watson, where she spent 10 years in leadership roles on the national health and benefits team. Brooke Bartholomay Quinn joins as Senior Vice President of Customer Success from…

Biovaxys Adds Charles J. Dunton, MD as Scientific Advisor to Support the Company’s Ovarian Cancer Vaccine Clinical Program and Papilocare Marketing

BioVaxys has announced that Charles J. Dunton, MD has joined BioVaxys as an Advisor to help provide additional scientific support for BVX-0918A, the Company’s ovarian cancer vaccine candidate, and its planned marketing and sale of Papilocare in the United States. Dr. Dunton, a top global opinion leader, is a gynecologist/oncologist in Indiana. He received his medical degree from Jefferson Medical College and has been in…

Male Contraception: Medical Device Industry Veteran Martin J. Emerson Joins Contraline’s Board

Contraline, a venture-backed medical device company devoted to providing men and couples with long-lasting, safe, and effective male contraception, has appointed medical device industry executive Martin Emerson to its Board of Directors. “Marty joins our Board at an exciting time as we transition to a clinical-stage organization and plan to initiate our first-in-human clinical trial of ADAM, the world’s first injectable hydrogel…